Group One Trading
SNDX icon

Group One Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Group One Trading’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
+4,861
New +$101K ﹤0.01% 4801
2026
Q1 		– Sell
-11,792
Closed -$256K – 8663
2025
Q4 		$248K Buy
+11,792
New +$206K ﹤0.01% 4184
2024
Q4 		– Sell
-11,752
Closed -$201K – 7913
2024
Q3 		$226K Buy
11,752
+9,434
+407% +$195K ﹤0.01% 3500
2024
Q2 		$47.6K Buy
2,318
+1,555
+204% +$32.5K ﹤0.01% 4553
2024
Q1 		$18.2K Sell
763
-25,074
-97% -$559K ﹤0.01% 5494
2023
Q4 		$558K Sell
25,837
-86,814
-77% -$1.33M ﹤0.01% 2979
2023
Q3 		$1.64M Buy
112,651
+111,374
+8,722% +$2.11M 0.01% 1816
2023
Q2 		$26.7K Sell
1,277
-880
-41% -$18.3K ﹤0.01% 5770
2023
Q1 		$45.6K Buy
2,157
+1,000
+86% +$24.9K ﹤0.01% 4920
2022
Q4 		$29.4K Buy
+1,157
New +$27K ﹤0.01% 5355
2021
Q3 		– Sell
-6,808
Closed -$113K – 8745
2021
Q2 		$117K Buy
6,808
+2,572
+61% +$47.1K ﹤0.01% 5805
2021
Q1 		$95K Sell
4,236
-9,785
-70% -$221K ﹤0.01% 5711
2020
Q4 		$312K Buy
+14,021
New +$291K ﹤0.01% 3708
2020
Q1 		– Sell
-21,132
Closed -$198K – 5713
2019
Q4 		$186K Sell
21,132
-854
-4% -$6.27K ﹤0.01% 3230
2019
Q3 		$164K Buy
21,986
+1,890
+9% +$17.2K ﹤0.01% 3228
2019
Q2 		$187K Buy
20,096
+13,504
+205% +$98.4K ﹤0.01% 2907
2019
Q1 		$35K Sell
6,592
-5,669
-46% -$32.3K ﹤0.01% 3752
2018
Q4 		$55K Buy
12,261
+3,246
+36% +$17.8K ﹤0.01% 3516
2018
Q3 		$73K Buy
9,015
+8,777
+3,688% +$62.6K ﹤0.01% 3743
2018
Q2 		$2K Buy
+238
New +$2.33K ﹤0.01% 4956
2018
Q1 		– Sell
-4,000
Closed -$42.5K – 5268
2017
Q4 		$35K Buy
+4,000
New +$39.6K ﹤0.01% 3910

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Group One Trading's SNDX Position: Q2 2026 in Review

Group One Trading opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 4,861 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #4801 among its holdings. This is a return to the name: Group One Trading previously reported a position in SNDX as recently as Q4 2025.

Group One Trading first reported a position in SNDX in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.64M in Q3 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Group One Trading held 4,861 shares of Syndax Pharmaceuticals worth $106K as of Q2 2026.
  • Syndax Pharmaceuticals was a new Group One Trading position in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4801 holding.
  • Group One Trading first reported a position in Syndax Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
  • Group One Trading's Syndax Pharmaceuticals position peaked at $1.64M in Q3 2023.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.